Viewing Study NCT04657302


Ignite Creation Date: 2025-12-25 @ 3:56 AM
Ignite Modification Date: 2025-12-26 @ 2:48 AM
Study NCT ID: NCT04657302
Status: COMPLETED
Last Update Posted: 2024-01-19
First Post: 2020-12-01
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study to Evaluate Glofitamab as Single Agent Administered After Pretreatment With Obinutuzumab in Chinese Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Sponsor: Hoffmann-La Roche
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module